sellModerate cluster of 310b5-1 plan
Saurabh Saha sold $682k of CNTA
Chief Executive Officer at Centessa Pharmaceuticals plc. 55,000 shares at an average of $12.39, traded Apr 21, 2025, filed Apr 22, 2025.
Warning score
46Value
$682k
55,000 shares
Holdings after
221,017
-20% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +21Trade size$682k at market
- +5Share of holdings soldSold 20% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000055, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 21, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -14,656 | $12.29 | $180k | 261,361 | Apr 22, 2025 |
| Apr 22, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -40,344 | $12.43 | $501k | 221,017 | Apr 22, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $1.2M 41,076 shares | -40% | |
| 19Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $720k 23,998 shares | -27% | |
| 33Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $2.1M 74,811 shares | -59% | |
| 33Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $3.2M 120,029 shares | -66% | |
| 48Moderate | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $1.9M 73,196 shares | -53% | |
| 50Moderate | CNTAsell Centessa Pharmaceuticals plc | Iqbal J Hussain Chief Legal Officer | $1.0M 39,961 shares | -38% | |
| 14Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $288k 10,000 shares | -5% | |
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $300k 10,000 shares | -5% | |
| 18Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $1.1M 40,000 shares | -25% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $166k 6,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.